Publicaciones (29) Publicaciones de GIRISH KUMAR SRIVASTAVA

2022

  1. Acute intraocular toxicity caused by perfluorocarbon liquids: safety control systems of medical devices

    Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 260, Núm. 7, pp. 2103-2110

  2. Advanced Therapy and Clinical Trials to Treat Patients with Optic Nerve Diseases

    Neurotoxicity Research, Vol. 40, Núm. 6, pp. 1739-1757

  3. Factors influencing mesenchymal stromal cells in in vitro cellular models to study retinal pigment epithelial cell rescue

    Human Cell, Vol. 35, Núm. 4, pp. 1005-1015

2021

  1. Intraocular toxicity caused by MEROCTANE perfluorocarbon liquid

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. Chemical compounds causing severe acute toxicity in heavy liquids used for intraocular surgery

    Regulatory Toxicology and Pharmacology, Vol. 110

  2. Mesenchymal Stem Cell Secretome Enhancement by Nicotinamide and Vasoactive Intestinal Peptide: A New Therapeutic Approach for Retinal Degenerative Diseases

    Stem Cells International, Vol. 2020

2019

  1. Acute retinal toxicity associated with a mixture of perfluorooctane and perfluorohexyloctane: Failure of another indirect cytotoxicity analysis

    British Journal of Ophthalmology, Vol. 103, Núm. 1, pp. 49-54

  2. Chemical considerations regarding the H-value methodology and its relation with toxicity determination

    Investigative Ophthalmology and Visual Science

  3. Mesenchymal stem cells provide paracrine neuroprotective resources that delay degeneration of co-cultured organotypic neuroretinal cultures

    Experimental Eye Research, Vol. 185

2018

  1. Biocompatibility of intravitreal injection of human mesenchymal stem cells in immunocompetent rabbits

    Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 256, Núm. 1, pp. 125-134

  2. Comparison between direct contact and extract exposure methods for PFO cytotoxicity evaluation

    Scientific Reports, Vol. 8, Núm. 1

  3. Retinal toxicity of medical devices used during vitreoretinal surgery: A critical overview

    Ophthalmologica, Vol. 240, Núm. 4, pp. 236-243

2017

  1. Acute retinal damage after using a toxic perfluoro-octane for vitreo-retinal surgery

    Retina, Vol. 37, Núm. 6, pp. 1140-1151

2016

  1. A novel coculture model of porcine central neuroretina expiants and retinal pigment epithelium cells

    Molecular Vision, Vol. 22, pp. 243-253

  2. Mesenchymal stem cell therapy in retinal and optic nerve diseases: An update of clinical t

    World Journal of Stem Cells

2014

  1. Basement membrane promotes ciliary body derived cell spheres formation

    Current Tissue Engineering, Vol. 3, Núm. 2, pp. 112-118

  2. Bioactive substrates for human retinal pigment epithelial cell growth from elastin-like recombinamers

    Journal of Biomedical Materials Research - Part A, Vol. 102, Núm. 3, pp. 639-646

  3. Chitosan feasibility to retain retinal stem cell phenotype and slow proliferation for retinal transplantation

    BioMed Research International, Vol. 2014

  4. Triple-layered mixed co-culture model of RPE cells with neuroretina for evaluating the neuroprotective effects of adipose-MSCs

    Cell and Tissue Research, Vol. 358, Núm. 3, pp. 705-716

2013

  1. Adalimumab (Tumor necrosis factor-blocker) reduces the expression of glial fibrillary acidic protein immunoreactivity increased by exogenous tumor necrosis factor alpha in an organotypic culture of porcine neuroretina

    Molecular Vision, Vol. 19, pp. 894-903